Education
About Us
Working with TipRanks
Follow Us
Sam Barker Insider Profile
4 Followers
Sam Barker, Director at Lexicon Pharmaceuticals, holds 124.46K shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 40.41K shares in Bio Green Med Solution (Ticker: BGMS), holds 0.00 shares in Cadence Pharma (Ticker: CADX).
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+1.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sam Barker holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Dec 02, 2021 - Dec 02, 2022
Return:+75.00%
The most profitable trade made by Sam Barker
Sam Barker's Trading History
Lexicon Pharmaceuticals
May 13, 2025
Director
Uninformative Buy
24.77K
$184.20K
Bio Green Med Solution
Jul 03, 2023
Director
Uninformative Buy
―
$40.37K
Cadence Pharma
Mar 21, 2014
―
Uninformative Sell
280.00K
―
List of latest transactions for each holding click on a transaction to see Sam Barker's performance on stock
You May Also Like
Sam Barker insider profile FAQ
What is the percentage of profitable transactions made by Sam Barker?
The percentage of profitable transactions made by Sam Barker is 40%.
What is the average return per transaction made by Sam Barker?
The average return per transaction made by Sam Barker is 1.90%.
What stocks does Sam Barker hold?
Sam Barker holds: LXRX, BGMS, CADX stocks.
What was Sam Barker’s latest transaction?
Sam Barker latest transaction was an Uninformative Buy of $24.77K.
What was Sam Barker's most profitable transaction?
Sam Barker’s most profitable transaction was an Informative Sell of BGMS stock on December 2, 2021. The return on the trade was 75.00%.
What is Sam Barker's role in Lexicon Pharmaceuticals?
Sam Barker's role in Lexicon Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.